Company / Total Debt
AYTU BIOPHARMA, INC Total Debt History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$10.9M
FY2025
5-year range
$10.9M / $15.0M
FY2022-FY2025
Trend
+0.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $15M to $11M over the past 2 years.
Based on SEC 10-K filings.
$11M in FY2025 with a 3-year CAGR of -10.1%.
Improved from $15M to $11M over the past 2 years.
Total Debt over time
Growth rates
- 3-Year CAGR
- -10.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -10.1%, indicating a declining trend.
- In FY2025, total debt increased 0.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.9M | +0.2% |
| FY2024 | $10.9M | -27.5% |
| FY2023 | $15.0M | +0.0% |
| FY2022 | $15.0M | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026